HNF1alpha controls renal glucose reabsorption in mouse and man.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  EMBO Reports

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11269503PMCID PMC1083745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins.

  1998cited by this paper
• Mutation screening in 18 Caucasian families suggest the existence of other MODY genes

  1998cited by this paper
• A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.

  1998cited by this paper
• Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.

  1998cited by this paper
• Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3).

  1997cited by this paper
• Hepatocyte nuclear factor 1alpha gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene

  1997cited by this paper
• Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

  1996cited by this paper
• Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome.

  1996cited by this paper
• Molecular Characteristics of Na+-coupled Glucose Transporters in Adult and Embryonic Rat Kidney *

  1995cited by this paper
• The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.

  1994cited by this paper
• SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation.

  1994cited by this paper
• More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing.

  1993cited by this paper
• vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression.

  1991cited by this paper
• A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain.

  1990cited by this paper
• HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF.

  1990cited by this paper
• Protein kinase C activation has dissimilar effects on sodium-coupled uptakes in renal proximal tubular cells in primary culture.

  1989cited by this paper
• The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain.

  1989cited by this paper
• A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells.

  1988cited by this paper
• Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Expression cloning and cDNA sequencing of the Na+/glucose co-transporter

  1987cited by this paper
• Factors involved in control of tissue-specific expression of albumin gene.

  1987cited by this paper
• Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

  1985cited by this paper
• Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule: evidence from vesicle studies.

  1982cited by this paper
• The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

  1982cited by this paper
• Mild familial diabetes with dominant inheritance.

  1974cited by this paper
• Observations on the mechanisms of glucosuria during glucose loads in normal and nondiabetic subjects.

  1968cited by this paper

• Chronic NH4Cl loading improves glucose tolerance without modifying insulin sensitivity in mice

  2026influential citation
• Distinct Roles of Common Genetic Variants and Their Contributions to Diabetes: MODY and Uncontrolled T2DM

  2025cites this paper
• The Abnormal Expression of Tubular SGLT2 and GULT2 in Diabetes Model Mice with Malocclusion-Induced Hyperglycemia

  2025cites this paper
• Determining gene specificity from multivariate single-cell RNA sequencing data

  2025cites this paper
• Sulphonylurea efficacy and end‐organ outcomes in the management of HNF4A‐MODY

  2025cites this paper
• Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 Diabetes

  2025cites this paper
• Decoding MODY: exploring genetic roots and clinical pathways

  2025cites this paper
• Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease

  2025cites this paper
• Gene therapy of Dent disease type 1 in newborn ClC-5 null mice for sustained transgene expression and gene therapy effects

  2024cites this paper
• Management of pregnancy in women with monogenic diabetes due to mutations in GCK, HNF1A and HNF4A genes

  2024cites this paper
• Clinical effects of SGLT2 inhibitors in seven persons with HNF1A‐MODY (MODY3)

  2024cites this paper
• SETD2 regulates SLC family transporter-mediated sodium and glucose reabsorptions in renal tubule.

  2024cites this paper
• Molecular characterization and re-interpretation of HNF1A variants identified in Indian MODY subjects towards precision medicine

  2023cites this paper
• HNF1A binds and regulates the expression of SLC51B to facilitate the uptake of estrone sulfate in human renal proximal tubule epithelial cells

  2023cites this paper
• Transcription factor c-Maf deletion improves streptozotocin-induced diabetic nephropathy by directly regulating Sglt2 and Glut2

  2023cites this paper
• Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease

  2022cites this paper
• Vertical Sleeve Gastrectomy Lowers SGLT2/Slc5a2 Expression in the Mouse Kidney.

  2022cites this paper
• A Case Report of a New Locus of Maturity-Onset Diabetes of the Young Type 3 (MODY3)

  2022cites this paper
• Where to for precision treatment of HNF1A-MODY?

  2022cites this paper
• HNF1A Mutations and Beta Cell Dysfunction in Diabetes

  2022cites this paper
• Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity

  2022cites this paper
• Insights into the Genetics and Signaling Pathways in Maturity-Onset Diabetes of the Young

  2022cites this paper
• An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells.

  2022cites this paper
• HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus

  2022cites this paper
• Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

  2022cites this paper
• How do I diagnose Maturity Onset Diabetes of the Young in my patients?

  2022cites this paper
• A brief history of diabetes genetics: insights for pancreatic beta-cell development and function.

  2021cites this paper
• A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY

  2021cites this paper
• Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY3.

  2021cites this paper
• The use of SGLT2 inhibitors in achieving glycaemic control in maturity-onset diabetes of the young type 3

  2021cites this paper
• Effects of SGLT2 Inhibitors on the Risks of Hypertension and Heart Failure in Diabetic Patients: A Systematic Review

  2021cites this paper
• Incidence of HNF1A and GCK MODY Variants in a South African Population

  2020cites this paper
• Hnf4a is required for the development of Cdh6-expressing progenitors into proximal tubules in the mouse kidney

  2020cites this paper
• Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes.

  2020cites this paper
• Hnf4a-mediated regulation of proximal tubule progenitors in the mouse kidney

  2020cites this paper
• Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment

  2020cites this paper
• Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury

  2020cites this paper
• A study of associations between CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery disease

  2020cites this paper
• Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application

  2020cites this paper
• 1,5-ANHYDROGLUCITOL IN PATIENTS WITH DIABETES: THE ROLE IN DIAGNOSTICS, SCREENING, GLYCEMIC STATUS ASSESSMENT AND PREDICTION OF COMPLICATIONS

  2020cites this paper
• TACG_A_281872 209..219

  2020cites this paper
• 1,5-ANHYDROGLUCITOL IN DIABETES: ITS ROLE IN DIAGNOSTICS, SCREENING, GLYCEMIC STATUS ASSESSMENT, AND THE PREDICTION OF COMPLICATIONS

  2020cites this paper
• Novel insights into genetics and clinics of the HNF1A-MODY

  2019cites this paper
• A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations

  2019cites this paper
• Transcriptional profiling of the zebrafish proximal tubule.

  2019cites this paper
• Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment

  2019cites this paper
• Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2019cites this paper
• Hepatic Nuclear Factor 1 Alpha (HNF-1α) in Human Physiology and Molecular Medicine.

  2019cites this paper
• Novel Mechanisms for IGF-I Regulation by Glucagon in Carp Hepatocytes: Up-Regulation of HNF1α and CREB Expression via Signaling Crosstalk for IGF-I Gene Transcription

  2019cites this paper
• Nucleosome Positioning and Gene Regulation of the SGLT2 Gene in the Renal Proximal Tubular Epithelial Cells

  2018influential citation
• Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options

  2018cites this paper
• Nephron segment-specific gene expression using AAV vectors

  2018cites this paper
• Clinical Management of Women with Monogenic Diabetes During Pregnancy

  2018cites this paper
• melli-Diagnostika MODY – stručný přehled pro klinickou praxi

  2018cites this paper
• High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection

  2018cites this paper
• Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives

  2018cites this paper
• The molecular functions of hepatocyte nuclear factors - In and beyond the liver.

  2017cites this paper
• Fifteen-minute consultation: Monogenic forms of diabetes with onset after age 6 months

  2017cites this paper
• Distribution of glucose transporters in renal diseases

  2017cites this paper
• The Na+‐D‐glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer

  2017cites this paper
• Empagliflozin: a new strategy for nephroprotection in diabetes

  2017cites this paper
• A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus

  2017cites this paper
• Is it time to think about the sodium glucose co‐transporter 2 sympathetically?

  2016cites this paper
• A suppressor locus for MODY3-diabetes

  2016cites this paper
• Hepatocyte nuclear factor 1 coordinates multiple processes in a model of intestinal epithelial cell function.

  2016cites this paper
• Investigating the relative contribution of obesity and glucose in the development of β-cell dysfunction

  2016influential citation
• Maturity onset diabetes of the young: Seek and you will find.

  2016cites this paper
• Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.

  2016cites this paper
• Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology

  2016cites this paper
• Tubular proteinuria in patients with HNF1α mutations: HNF1α drives endocytosis in the proximal tubule.

  2016cites this paper
• Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize Treatment.

  2016cites this paper
• Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes

  2015cites this paper
• Maturity-onset diabetes of the young (MODY): an update

  2015cites this paper
• Monogenic diabetes and pregnancy

  2015cites this paper
• Sex-Differences in Renal Expression of Selected Transporters and Transcription Factors in Lean and Obese Zucker Spontaneously Hypertensive Fatty Rats

  2015cites this paper
• Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?

  2015cites this paper
• Phytochemical inhibition of intestinal and kidney glucose transporters expressed in the Xenopus laevis oocyte system

  2015cites this paper
• Many faces of monogenic diabetes

  2014cites this paper
• Identifying subtypes of monogenic diabetes

  2014cites this paper
• Identification de loci suppresseurs du phénotype diabétique lié à la déficience en Hnf1a chez la souris

  2014cites this paper
• Caractérisation de l’effet de mutations MODY sur la fonction de bookmarking de HNF1beta

  2014cites this paper
• Familial renal glycosuria and modifications of glucose renal excretion.

  2014cites this paper
• Hypouricaemia and hyperuricosuria in familial renal glucosuria

  2013cites this paper
• Pathogenesis of the Metabolic Syndrome: Insights from Monogenic Disorders

  2013cites this paper
• Maturity onset diabetes of the young: identification and diagnosis

  2013cites this paper
• Glucose transport families SLC5 and SLC50.

  2013cites this paper
• SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes?

  2013cites this paper
• RD Lawrence Lecture 2012 Assessing aetiology in diabetes: how C‐peptide, CRP and fucosylation came to the party!

  2013cites this paper
• Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity‐Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia

  2013cites this paper
• Molecular diagnosis of maturity onset diabetes of the young in India

  2013cites this paper
• 1,5-Anhydroglucitol in diabetes mellitus

  2013cites this paper
• SGLT2 Inhibition: A Novel Prospective Strategy in Treatment of Diabetes Mellitus

  2013cites this paper
• Discovering Genes Responsible for Kidney Diseases

  2013cites this paper
• Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies

  2012cites this paper
• Metabolic Profiling in Maturity-Onset Diabetes of the Young (MODY) and Young Onset Type 2 Diabetes Fails to Detect Robust Urinary Biomarkers

  2012cites this paper
• Metabolic Syndrome and Obesity : Targets and Therapy Clinical features and treatment of maturity onset diabetes of the young ( MODY )

  2012cites this paper
• Cystatin C is not a good candidate biomarker for HNF1A-MODY

  2012cites this paper
• An overview of transcriptional regulation in response to toxicological insult

  2012cites this paper
• SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

  2012cites this paper
• Die Funktion des gewebespezifischen Transkriptionsfaktors HNF1beta in der Nierenentwicklung von Xenopus laevis

  2012cites this paper